HoldingsChannel.com
Aisling Capital Management LP Top Holdings
As of  03/31/2019

   EntityAmountChange
 12/31/2018 to 03/31/2019
Position Size
($ in 1000's)
Eidos Therapeutics Inc. EIDIX 1,123,630 UNCH $26,349
     EIDX1,123,630UNCH$26,349
AVROBIO Inc. AVRO 811,998 +75,000 $17,905
     AVRO811,998+75,000$17,905
ObsEva SA OBSV 1,386,338 UNCH $17,731
     OBSV1,386,338UNCH$17,731
Biohaven Pharmaceutical Holding Company Ltd. BHVN 274,513 UNCH $14,129
     BHVN274,513UNCH$14,129
Marker Therapeutics Inc. MRKR 2,000,000 UNCH $13,200
     MRKR2,000,000UNCH$13,200
Aeglea Biotherapeutics Inc AGLE 1,220,911 +352,290 $9,828
     AGLE1,220,911+352,290$9,828
Sunesis Pharmaceuticals Inc. SNSS 7,600,000 +5,000,000 $9,234
     SNSS7,600,000+5,000,000$9,234
Zosano Pharma Corporation ZSAN 1,600,000 UNCH $7,632
     ZSAN1,600,000UNCH$7,632
Nabriva Therapeutics plc NBRV 1,809,259 UNCH $4,415
     NBRV1,809,259UNCH$4,415
Arcus Biosciences Inc. RCUS 333,333 -203,180 $4,163
     RCUS333,333-203,180$4,163
Aclaris Theraputics Inc ACRS 634,455 UNCH $3,800
     ACRS634,455UNCH$3,800

See Full List: All Stocks Held By Aisling Capital Management LP
Including:
     • Biggest exits
     • Biggest increased positions
     • Biggest decreased positions

See Details: Top 10 Stocks Held By Aisling Capital Management LP

Size ($ in 1000's)
At 03/31/2019: $131,269
At 12/31/2018: $94,914

Aisling Capital Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Aisling Capital Management LP 13F filings. Link to 13F filings: SEC filings

Aisling Capital Management LP Top Holdings 13F Filings | www.HoldingsChannel.com

Copyright © 2013 - 2019, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.